Author:
Chang Jae Won,Park Ki Wan,Heo Jae Hyung,Jung Seung-Nam,Liu Lihua,Kim Sung Min,Kwon In Sun,Koo Bon Seok
Publisher
Springer Science and Business Media LLC
Reference31 articles.
1. Lee JW, Lee SM, Lee DH et al (2013) Clinical utility of 18F-FDG PET/CT concurrent with 131I therapy in intermediate-to-high-risk patients with differentiated thyroid cancer: dual-center experience with 286 patients. J Nucl Med 54:1230–1236
2. Rosenbaum-Krumme SJ, Gorges R, Bockisch A et al (2012) (1)(8)F-FDG PET/CT changes therapy management in high-risk DTC after first radioiodine therapy. Eur J Nucl Med Mol Imaging 39:1373–1380
3. Robbins RJ, Wan Q, Grewal RK et al (2006) Real-time prognosis for metastatic thyroid carcinoma based on 2-[18F]fluoro-2-deoxy-d-glucose-positron emission tomography scanning. J Clin Endocrinol Metab 91:498–505
4. Wang W, Larson SM, Fazzari M et al (2000) Prognostic value of [18F]fluorodeoxyglucose positron emission tomographic scanning in patients with thyroid cancer. J Clin Endocrinol Metab 85:1107–1113
5. Bertagna F, Treglia G, Piccardo A et al (2012) Diagnostic and clinical significance of F-18-FDG-PET/CT thyroid incidentalomas. J Clin Endocrinol Metab 97:3866–3875
Cited by
9 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献